Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

NCT01671280

Last updated on March 15, 2019

To collect the efficacy and safety information of Azithromycin IV related to their appropriate use in daily practice

Study Location

Contact

1-800-718-1021

C[email protected]

Eligibility criteria

Condition

Pneumonia, Pelvic Inflammatory Disease

Sex

Females and Males

Age

0 +

Inclusion criteria

Show details

- Male or Female patients who are prescribed Zithromac IV for pneumonia or pelvic
inflammatory disease.

Exclusion criteria

Show details

- Subjects who have been prescribed Zithromac IV for pneumonia or pelvic inflammatory
disease.

NCT01671280

Pfizer

Completed

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021